EAG, INC.
SANTA CLARA, CA

Whether connecting the internet of things, guiding surgical lasers or powering the latest smart phone, integrated circuits and microelectronics touch nearly every aspect of human life. In the world of technology, innovation and continuous improvement are imperatives—and being able to quickly and reliably test, debug, diagnose failures and take corrective action can make the difference between a doomed product launch and building a successful global brand. EAG offers you the world’s largest and most diverse collection of specialized analytical instrumentation, capacity to perform a variety of microelectronic tests in parallel, and the multi-disciplinary expertise required to draw true insight from data. Established as Chemir/Polytech Laboratories to provide R&D analytical support to the industrial and consumer products industries. PTRL Europe has grown to become a European leader in organic analytical chemistry and excels in areas of pesticide residue analysis, characterization of technical products and impurities, metabolites and degradates. A leader in metallurgical analysis, traditionally serving defense, aerospace, industrial products, and medical device industries; SEAL is a pre-eminent name in scientifically based expert witness testimony. GLP and cGMP-compliant contract research organization providing product development, analytical testing, custom synthesis and radiolabeling services, serving the global pharmaceutical, agrochemical, chemical and related industries. EAG is committed to excellence in our professional practices, to offering world-class analytical testing services, and to continually improving our quality management system. Our mission to achieve total customer satisfaction by delivering on-time, accurate analyses is engraved in the backbone of our quality system. In keeping with this commitment, we have a number of controls in place to assure the effectiveness and efficiency of our quality system: Objectives and targets that measure and monitor client satisfaction, product conformity, and process efficiency Audits along with regulatory inspections conducted at regular intervals to ensure the ongoing effectiveness of EAG’s quality system Depending on our clients’ needs, labs within EAG have various certifications, accreditations, regulatory approvals and/or licenses. Competition is fierce. Regulations are increasingly complex. Special interests and litigation are always a threat. In this environment, innovation, safety and sustainability are the very lifeblood of products and companies. With so much at stake, doesn’t it make sense to put leading-edge science on your side? We help companies across a broad range of technically demanding industries do just that. Hear success stories from some of our employees… Ask EAG | We Know How Siddhartha C. Kadia joined EAG as President and Chief Executive Officer in April, 2014. Prior to EAG, Siddhartha served as the President of the Life Sciences Division of Life Technologies Corporation where he was responsible for worldwide P&L of a $2B of portfolio, which included many differentiated technologies, including proprietary reagents franchises and a bioproduction business. Industry leading brands including Invitrogen, GIBCO, Dynal, Ambion, Molecular Probes and Novex were part of this portfolio. Previously, Siddhartha served in various executive roles at Life Technologies, including President , Life Technologies Greater China (2011-2013), President, Life Technologies Japan Ltd. (2009-2011) and Chief Marketing Officer (2008-2009). He also served on the Board for Life Technologies Foundation and on the Board of Life Technologies DaAn Diagnostics, a China-based joint venture he established. From July 2005 to July 2008, he served in numerous roles at Invitrogen Corporation, including Vice President, Global Marketing and eBusiness. Invitrogen merged with Applied Biosystems, Inc. in 2008 to form Life Technologies. Before joining Invitrogen, Siddhartha C. Kadia was a management consultant at McKinsey & Company where his work focused on healthcare related engagements: assisting medical device companies from the US and Europe in developing strategic direction and improving earnings, advising local and state governments in the U.S. on healthcare spend effectiveness, and consulting with medium and large U.S. healthcare providers in improving profitability. Siddhartha served on the board of directors of Newport Corporation, a leading global supplier of advanced technology products and solutions for scientific research, life & health science, aerospace & defense, photovoltaics, industrial manufacturing, semiconductors, and microelectronics markets. Newport Corporation became part of MKS Industries in April, 2016. Siddhartha previously served on the board of directors of Volcano Corporation, a medical technology company that was sold to Royal Philips in February 2015. Amanda Halford joined EAG as its first Chief Commercial Officer in 2015 and assumed the responsibilities of Executive Vice President of our Life Sciences division last year. Prior to joining EAG, Amanda spent 15 years at Sigma Aldrich in a variety of roles, most recently as Vice President of the Academic Research business where she was responsible for the global business for the full portfolio of products and services to the Academic, Government and Hospital sectors. Amanda led the strategic review for the business, repositioning into the academic translational research segment and driving market share growth. Amanda also led Sigma-Aldrich’s business development and scientific collaborations within these sectors. During her 15 year tenure at Sigma Aldrich, Amanda held positions of increasing responsibility in Marketing, Process Improvement, Corporate Strategy and Development and eBusiness. Amanda’s titles included Vice President of eBusiness, Vice President of the Chemistry and Materials Science business and Director of Marketing for SAFC As VP, eBusiness, managing the global online channel for Sigma Aldrich with a focus on customer insight, user experience, business analytics and digital marketing there was a significant increase in new customers to the site, increased customer loyalty on the site and significantly increased revenue through the channel.